Michael J. Murry

Catalytica Energy Systems, Inc. provides innovative products and services to meet the rapidly growing demand for emissions control solutions in the power generation and transportation industries. The company offers variety of services for coal-fired power plants using selective catalytic reduction (SCR) systems to reduce nitrogen oxides (NOx) emissions. The business activities include the design, development and manufacture of advanced products based on its proprietary catalyst and fuel processing technologies to offer cost-effective solutions for reducing NOx emissions from diesel engines and natural gas-fired turbines. The company is located in Gilbert, AZ.

Vibrantz Corp. engages in the business of manufacturing specialty materials. Its products include frits, porcelain and other glass enamels, glazes, stains, decorating colors, pigments, inks, polishing materials, dielectrics, electronic glasses and other specialty coatings. The company was founded by Harry D. Cushman, Raymond Williams, and Henry Luebbert in 1919 and is headquartered in Mayfield Heights, OH.

Wheaton Franciscan Services, Inc. operates a chain of healthcare and shelter service organizations in Colorado, Illinois, Iowa, and Wisconsin. Its operating portfolio includes hospitals, long-term care facilities, and clinics. The company was founded in 1983 and is based in Wheaton, Illinois. Through its Wheaton Franciscan Healthcare division, WFSI operates hospitals including Affinity Health System, Marianjoy, Rush Oak Park Hospital, and United Hospital System. Its Franciscan Ministries division provides affordable housing units including assisted living facilities and housing for people living with HIV/AIDS. WFSI also includes home health agencies and physician offices. The health system was founded in 1983 and is sponsored by The Franciscan Sisters, Daughters of the Sacred Hearts of Jesus and Mary.

Pfanstiehl, Inc. develops endotoxin injectable formulation and pharmaceutical ingredients. The firm specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin injectable formulation ingredients, pharmaceutical intermediates and active pharmaceutical ingredients. The company was founded by Carl A. Pfanstiehl in 1919 and is headquartered in Waukegan, IL.